The Classification of Calcium Antagonists and their Selection in the Treatment of Hypertension
- 1 January 1998
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 55 (4), 509-517
- https://doi.org/10.2165/00003495-199855040-00003
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With EnalaprilCirculation, 1997
- Differential Activation of Cardiac and Peripheral Sympathetic Nervous System by Nifedipine: Role of PharmacokineticsJournal of the American College of Cardiology, 1997
- "Cardioprotection"--not all calcium antagonists are created equal: second round.1997
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- Structure and Function of the Rat Basilar Artery During Chronic Nitric Oxide Synthase InhibitionStroke, 1995
- AmlodipineDrugs, 1995
- The endothelium in hypertension: bystander, target or mediator?1994
- Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses.1993
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990